Business Context and Reporting Period
This Form 8-K was filed by Aytu BioScience, Inc. on February 19, 2020. The company is incorporated in Delaware and its common stock trades on The NASDAQ Stock Market LLC under the symbol "AYTU".
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on a regulatory listing status update rather than financial performance.
Material Changes
The primary material event reported is the receipt of a notice from The Nasdaq Stock Market LLC indicating the company failed to comply with the minimum bid price requirement of Nasdaq Listing Rule 5550(a)(2). Specifically, the company's common stock did not maintain a minimum closing bid price of at least $1.00 per share.
Outlook, Risks, and Management Commentary
- Compliance Grace Period: Under Nasdaq Listing Rule 5810(c)(3)(A), the company has a 180-calendar-day grace period to regain compliance.
- Compliance Standard: To satisfy the requirement, the company must achieve a minimum closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days within the grace period.
- Management Action: The company is monitoring the bid price of its common stock and will consider available options to achieve compliance.
- Risk: Failure to regain compliance within the grace period could result in delisting from the Nasdaq Capital Market.
Investor Verification Checklist
- Verify the current trading price of AYTU stock to assess proximity to the $1.00 threshold.
- Monitor future 8-K filings for updates on compliance efforts or potential reverse stock splits.
- Review the company's most recent 10-K or 10-Q for financial health context, as this 8-K contains no financial data.
- Confirm the exact expiration date of the 180-day grace period based on the February 19, 2020 notice date.